Montserrat Torrebadell Burriel

Montserrat Torrebadell Burriel

Investigador

Research line:

Leukemias and non-neoplastic hemopathies

Montserrat Torrebadell obtained in 1998 his Bachelor of Medicine and Surgery from the University of Barcelona. In 2005 Specialty in Hematology and Hemotherapy at the Hospital Clinico de Barcelona. In 2018 she presented his doctoral thesis at the University of Barcelona: "Anàlisi del valor pronòstic del perfil d'expressió gènica en la leucèmia mieloblàstica aguda de risc citogenètic intermig segons l'opció terapèutica post-remissió".

She currently works as an associate medical specialist, specialist in charge of the cytometry area. Laboratory Diagnostic Service, Hematology Laboratory of the Sant Joan de Déu Hospital in Barcelona since 2010. She is also coordinator of the Biological Group of Acute Myeloid Leukemia (LMA) of the Spanish Society of Pediatric Hematology and Oncology and the Spanish representative of the committee biological in LMA in the international cooperative group NOPHO, which is an integral part of the IBFM group. Her main research interests are: application of flow cytometry techniques in the diagnosis and monitoring of patients with leukemia, biological characterization of patients with AML.

Professional network profiles

Related websites

Last Publications

More Publications

Projects

Project name:
Estudio multicéntrico fase 2 en pacientes pediátricos (0-18 años) con leucemia linfoblástica aguda B CD19+ en recaída o refractaria
Leader
Susana Rives Solà
Funding entities:
Instituto de Salud Carlos III (ISCIII)
Code
ICI21/00033
Starting - finishing date:
2022 - 2025
Project name:
SGR 2022-2024_Grup de recerca en tumors del desenvolupament
Leader
Jaume Mora Graupera
Funding entities:
Agaur - Agència de Gestió d'Ajuts Universitaris i de Recerca
Code
2021 SGR 01612
Starting - finishing date:
2022 - 2025
Project name:
Análisis de los factores pronósticos de fracaso del tratamiento tras terapia con células T con receptores antigénicos quiméricos (CAR-T) en pacientes pediátricos con leucemia linfoblástica aguda de línea B
Leader
Susana Rives Solà, Montserrat Torrebadell Burriel
Funding entities:
Instituto de Salud Carlos III (ISCIII), Fundació Privada per a la Recerca i la Docència Sant Joan de Déu - FSJD
Code
PI21/00218
Starting - finishing date:
2022 - 2024
More projects

News

See All news

More activities

More activities